Search

Search Constraints

You searched for: Author/Creator Mansutti, Mauro

Search Results

1. Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis. (February 2017)

2. Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy. (12th March 2018)

3. Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey. (August 2018)

4. Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial. Issue 10 (October 2021)

5. Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID‐19 Pandemic. (19th February 2021)

6. First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study. (June 2021)

7. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial. Issue 12 (December 2022)

8. Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario. (2nd May 2014)

9. Measures of Outcome in Metastatic Breast Cancer: Insights From a Real‐World Scenario. (2nd May 2014)

10. Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study. Issue 2 (February 2018)